News & Updates
Filter by Specialty:

Singapore faces high asthma burden
Singapore is disproportionately burdened by asthma, with related hospitalizations and emergency department (ED) visits occurring twice as often as the average of other developed countries, according to a study.
Singapore faces high asthma burden
05 Jan 2024
Various types of cancer screening can lead to early detection of disease and better awareness
Cancer cases are on the rise in Malaysia with a significant impact on the population’s health. According to the Ministry of Health (MOH), 1-in-10 men and 1-in-9 women are at risk of being diagnosed with cancer during their lifetime.
Various types of cancer screening can lead to early detection of disease and better awareness
05 Jan 2024
One in five community-dwelling older adults has mild neurocognitive disorders
Mild neurocognitive disorders (NCDs) are present in one in five community-dwelling older adults in Hong Kong, while 70 percent of older adults living in residential care homes have dementia, researchers from the Chinese University of Hong Kong (CUHK) have reported.
One in five community-dwelling older adults has mild neurocognitive disorders
04 Jan 2024
Expert highlights early detection of online, gaming addiction in children leads to mental resilience later in life
It is extremely important to safeguard children’s mental health in the digital age. Recognizing the signs of online and gaming addiction early and providing early assistance as well as a supportive environment are vital for children to become mentally resilient adults, says Dr Tee Bee Chin.
Expert highlights early detection of online, gaming addiction in children leads to mental resilience later in life
04 Jan 2024
Intranasal neuroEPO slows Alzheimer’s progression
An intranasally administered recombinant human erythropoietin without erythropoietic activity and shorter plasma half-life (neuroEPO) restores cognitive function or delays progression in most patients with mild-to-moderate Alzheimer’s disease, results of the phase II/III double-blind, placebo-controlled ATHENEA trial have shown.